Objective-To establish the time of onset of dilated cardiomyopathy (DCM) by review of annual chest x rays, which are obligatory in Hungary. Design-A retrospective survey of chest x rays of a cohort of confirmed cases of DCM, to assess time of onset of cardiomegaly. Clinical course was compared by follow up over a mean of six years from the time of diagnosis. Subjects-240 patients with DCM (31 familial, 209 non-familial). Diagnosis was made by echocardiography in all cases and confirmed by coronary angiography and heart biopsy in some cases. Main results-At diagnosis, the mean age of the patients was 31-8 years in the familial group and 39-6 years in the nonfamilial group (P < 0.05). The time between the onset of cardiomegaly (cardiothoracic ratio >0.45) and clinical diagnosis was 8-0 and 1041 years respectively (P < 0.05). The six year survival was 6% in the familial group and 23% in the non-familial group (P < 0.05).
Recent data'-3 show that familial dilated cardiomyopathy (DCM) is a not such a rare disease as was earlier believed. However, our knowledge about the age of onset of this form of cardiomegaly is limited as we only know the time of the onset of the clinical symptoms and signs of the disease. The clinical course of DCM is apparent only after the diagnosis has been made, while the real start of the disease before the onset of symptoms remains hidden. In Hungary, annual chest x ray screening is obligatory, and we are therefore in a position to acquire information retrospectively on the earlier "latent" period of the disease. The changes in heart size of DCM patients can be analysed by means of the cardiothoracic ratio, and the extent of cardiomegaly can be characterised by the increase in the ratio. For this study, we selected patients on whom previous annual cardiothoracic ratio data were available. These patients were examined and followed very thoroughly, allowing us not only to determine the onset of cardiomegaly, but also to follow up the progression of the disease. Considerable differences were found in the survival rates of the patients, with four year survival rates of 9-1% and 45 9%, and six year survival rates of 6% and 29%, in the familial and non-familial groups, respectively (fig 2) . By the end of the six year follow up period, 29 of the 31 familial DCM patients had died (94% mortality), while 160 of the 209 patients in the non-familial group had died (77% mortality) (table).
Methods
All the above mentioned differences were statistically significant (P < 0-05). The data show that the familial form of DCM is more malignant than the sporadic form; it occurs at an earlier age and progresses more rapidly. Familial DCM was previously considered to Time (months) be a rare disease.7-9 Our group was among the first to describe the existence of familial dilated (congestive) cardiomyopathy, and our ilts interest has focused particularly on the familial iagnosis, the mean age of the patients was form of the disease.1
Detailed examination (SD 10-2) years in the familial group, of the families of our familial DCM patients 39-6 (7-2) years in the non-familial showed 31 families in which at least two (but p. In both groups, the onset of cardio-frequently more) family members were aly preceded the onset of clinical symp-involved. The incidence of the familial form and signs (that is, the diagnosis) by 8-0 was earlier found to be 21 5%.12 Researchers and 10-1 (3-9) years, respectively, from the Mayo group reported a similar inciirring at the age of 23-8 years and 29-5 dence,'3-'5 and other investigators also believe s on average (fig 1) . Figure 3 Example of enlargement in heart size of one of our patients with dilated cardiomyopathy.
the complaints and symptoms occur and the diagnosis is made, only the tip of the iceberg can be seen; the point at which the disease began is unknown, and the onset of the cardiomegaly is likely to be an earlier manifestation than the symptoms. In Hungary, annual chest x ray screening for pulmonary tuberculosis is obligatory, and thus a good opportunity was available for us to study heart size retrospectively by measuring the cardiothoracic ratio and thereby obtain information on the previous latent period of the disease. Figure 3 shows a series of annual chest x ray pictures from one of our familial DCM patients. It is obvious that the increase in heart size was gradual, and the "latent" period lasted for 11 years in this case.
In both familial and non-familial DCM, the cardiomegaly (cardiothoracic ratio >0 45) preceded the onset of the first complaints by 8-10 years. These findings are of interest. First, they show that the influenza-like complaints around the time of the diagnosis are not of great importance, as might once have been thought. Secondly, the objective cardiothoracic data prove that the onset of cardiomegaly occurs at a younger age in familial DCM cases than in the non-familial form. It is by no means certain that familial congestive cardiomyopathy is a completely uniform disease; with expanding knowledge, further subgroups may well be distinguished in the future.
The contribution of a genetic factor to the development of familial DCM has recently been discussed, with the conclusion that genetic transmission is detectable in over 20-25% of the patients.'317 The introduction of molecular genetics into the study of familial cardiomyopathies has given further support to the hypothesis of the heterogeneity of the dilated form. Besides the earlier manifestation of the familial form, its progression is also more rapid than in the non-familial cases. The clinical significance of this observation is that the rapid progression of familial DCM should be taken into consideration in scheduling heart transplantation. '8 
